Refractory/Relapsed Systemic Lupus Erythematosus
1 clinical trials · Condition
◉ Watch Refractory/Relapsed Systemic Lupus Erythematosus
| Record | Firm | Date |
|---|---|---|
| Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases (NCT07490275) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-01 |
Track Refractory/Relapsed Systemic Lupus Erythematosus automatically
Every clearance here is in the API, with alerts when new ones post.